openPR Logo
Press release

Mild Laxatives Market Display Significant Growth by 2018 to 2028

08-03-2018 02:00 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact. MR

Mild Laxatives Market Display Significant Growth by 2018 to 2028

Constipation is a commonly occurring digestive disorder and its prevalence is anticipated to only increase over time due to lifestyle changes. Approximately 2% to 27% people worldwide are affected by constipation and self-reported constipation rate stands at 27.2%. Approximately 85% of the doctors prescribe mild laxatives for constipation. The high prescription rate of mild laxatives will create huge opportunities for growth of the mild laxatives market during the forecast period. Mild laxatives are medicines used to relieve a person of constipation. Mild laxatives always provide sustained relief from constipation symptoms. Every year, 2 to 3 million patients are prescribed laxatives by healthcare practitioners in the United States. Mild laxatives are available over the counter. The main mild laxatives used for constipation are bulk-forming laxatives, osmotic laxatives, stimulant laxatives and stimulant laxatives. Bulk-forming laxatives are most common laxatives recommend to the patients to increase slow transit time.

Request for Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=964

Mild Laxatives Market: Drivers and Restraints

The growing prevalence and recurrence of constipation is expected to be the major factor driving the growth of the mild laxatives market over the forecast period. Inactive lifestyle and unhealthy eating habits, irregular eating timings, lack of exercise and fewer sleep hours can be held responsible for the growing prevalence of constipation. Obesity is also a major factor responsible for increasing constipation problems. Rising obesity cases make another reason for the growth of the mild laxative market. Mild laxatives are safe to use for pregnant women and kids, which will create more growth opportunities for the players in the mild laxatives market. Over the counter product availability in the market will be a major factor expected to drive the mild laxatives market. The high prescription rate of mild laxatives for primary constipation treatment is expected to boost the growth of the mild laxatives market. Side effects associated with some mild laxatives are some of the factors expected to restrain mild laxatives market.

Mild Laxatives Market: Segmentation

Tentatively, the global mild laxatives market can be segmented on the basis of product type, distribution channel and geography.

Based on product type, the global mild laxatives market is segmented as:

Bulk-Forming Laxatives
Osmotic Laxatives
Stimulant Laxatives
Stimulant Laxatives
Based on distribution channel, the global mild laxatives market is segmented as:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Supermarket
Online Pharmacies
Mild Laxatives Market: Overview

The global market for mild laxatives is expected to witness moderate growth over the forecast period. Majority of the laxatives are introduced in the generic market and thus, there exists high competition among local and regional players. Among the product types, the bulk-forming laxatives are expected to lead in the global mild laxatives market over the forecast period. The Retail pharmacy distribution channel is expected to contribute high share in the global mild laxatives market as it is the most accessible channel and the majority of patients are recommended for outpatient treatment.

Mild Laxatives Market: Regional Outlook

Geographically, the global mild laxatives market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global mild laxatives market owing to the high prevalence of constipation. Constipation is the most common digestive complication in the United States. The mild laxatives market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of the product offerings by the key players. Europe is expected to hold the second large share in the global mild laxatives market throughout the forecast period owing to growing awareness regarding health-related problems.

Visit For TOC @ https://www.factmr.com/connectus/sample?flag=T&rep_id=964

Mild Laxatives Market: Key Players

Some of the key players operating in the global mild laxatives market are Bayer AG, GlaxoSmithKline Plc., Procter & Gamble Company, Abbott Laboratories, C. H. Boehringer Sohn AG & Co. KG, Sebela Pharmaceuticals, Inc., Purdue Pharma L.P., Takeda Pharmaceutical Company Ltd among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mild Laxatives Market Display Significant Growth by 2018 to 2028 here

News-ID: 1161728 • Views:

More Releases from Fact. MR

Mental Fitness Apps Market: A Leading Revenue Contributor, Forecasted to Grow at 16.7% CAGR till 2033
Mental Fitness Apps Market: A Leading Revenue Contributor, Forecasted to Grow at …
In 2023, the global market for mental fitness apps is valued at US$ 551.44 million and is anticipated to undergo rapid expansion, surging at a Compound Annual Growth Rate (CAGR) of 16.4% to reach US$ 2.52 billion by 2033. The escalating adoption of mental health applications is attributed to their transformative impact on lifestyle enhancement and treatment efficacy. Additionally, a growing societal awareness surrounding mental well-being is driving heightened demand for
Demand for the Point of Care Diagnostics Market is projected to reach a value of US$ 8,83,156.2 million by 2034
Demand for the Point of Care Diagnostics Market is projected to reach a value of …
In 2020, the Point of Care Diagnostics market size reached US$ 34.1 Billion, and it is expected to reach US$ 66 Billion by 2028. The Compound Annual Growth Rate (CAGR) during the forecast period from 2021 to 2028 is projected to be 7%. Market Dynamics: The Point of Care Diagnostics market is propelled by several key factors. First and foremost is the rising prevalence of infectious diseases and chronic conditions worldwide. The
Ceramic Coatings Market Value Is Expected To Increase At A CAGR Of Around 8.2% B …
The Ceramic Coatings market is estimated at US$ 7.4 Bn in 2022 and is projected to reach at a valuation of US$ 15.8 Bn by 2032, expanding at a CAGR of 8.2% during the forecasted period of 2022-2032. Ceramic coatings are made up of components like Silica, Silicon carbide, Alumina-magnesia, Alumina, Titania, and Silicon nitride. It is an inorganic substance which is made and well as applied at high temperatures. Ceramic
High Speed Ovens Market to Hit US$ 10.70 Billion By 2033
The global high speed ovens market is estimated at US$ 5.59 billion in 2023. Overall market value is expected to reach US$ 10.70 billion by 2033, expanding at a healthy CAGR of 6.7% from 2023 to 2033. High speed ovens are a type of cooking appliance that uses convection, microwave, and radiant heating technologies to cook food quickly. They are also referred to as accelerated cooking ovens or rapid cook ovens.

All 5 Releases


More Releases for Mild

Global Mild Hybrid Vehicles Market Research Report 2022-2029 | Global Mild Hybri …
Global Mild Hybrid Vehicles Market Analysis 2022-2028 Report provides strategists, marketers and senior management with the critical information they need to assess the global Mild Hybrid Vehicles Market as it emerges from the Covid-19 shut down. The impact of Coronavirus (COVID-19) on global market has reinforced many trends already shaping the industry pre COVID-19, There is a long-term trend towards the repositioning of players as entertainment providers on multiple platforms. This
Mild-to-Moderate Atopic Dermatitis Treatment Market: Lucrative Opportunities
Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often localized to the flexural surfaces of the body and usually begins in childhood. This skin disease affects a large percentage of the world's population. Atopic dermatitis, commonly known as eczema, is characterized by dry skin, itching, redness, swelling, vesicle formation, cracking, weeping, crusting, and scaling. Atopic dermatitis is a long-term skin disease, which is classified into different types depending on
Mild Laxatives Market Strategies and Forecasts, 2018 to 2028
Bulk-Forming Laxatives Product Type to Gain Significant Traction in Mild Laxatives Market Bulk-forming laxatives helps in absorbing liquid in intestines, resulting in softer and easier passage of stools, which in turn positively impacts the growth of mild laxatives market. Demand for bulk-forming laxatives is anticipated to make impressive growth in mild laxatives market owing to its less risk chances of explosive or cramping diarrhea, which is otherwise likely to take place
2018 Mild Cognitive Impairment Global Clinical Trials Review, H2, 2017
ResearchMoz presents Professional and In-depth Study of "Mild Cognitive Impairment Global Clinical Trials Review, H2, 2017" with coming years Industries Trends, Projections of Global Growth, Major Key Player and Case Study, Review, Share, Size, Effect. ' ' GlobalData's clinical trial report, Mild Cognitive Impairment Global Clinical Trials Review, H2, 2017" provides an overview of Mild Cognitive Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on
Mild Steel Market Latest Trends, Demand and Analysis 2017 – 2027
Mild Steel is also referred to as plain carbon steel or low carbon steel as it contains a very small percentage of carbon which makes it tough and strong but not readily tempered. The percentage of carbon is sometimes altered in steel to change its physical properties.Almost every heavy engineering and construction industry is always in search of a variety of steel which can be used for a wide range
Mild Cognitive Impairment - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment - Pipeline Review, H1 2017, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape. Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering) . MCI is an intermediate stage between the expected cognitive decline of normal aging and the more serious decline of dementia. Symptoms include depression,